yep and to get all of them RSH has to get FDA approval, Launch in Europe and be an ASX 300 company... not to mention their strike prices go all the way up to 60 cents... IMO that means management has $1.00 plus in their plan!
I say give these guys another 100m options the more they make the more I make...
I bought in at 8 cents I have this thing down for a 10-15 bagger!
No free options here only real shareholder value being created.
go research Dexcom they only have one product in the diabetes monitoring space... go research Remed they only have one type of product in a single disease state...
I am luck enough to own significant amounts of both since IPO (showing my age)... RSH will be my third golden goose! IMO DYOR
RSH Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held
